These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 17356528

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Effect of sibutramine on weight loss and blood pressure: a meta-analysis of controlled trials.
    Kim SH, Lee YM, Jee SH, Nam CM.
    Obes Res; 2003 Sep; 11(9):1116-23. PubMed ID: 12972682
    [Abstract] [Full Text] [Related]

  • 44. Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus.
    Fujioka K, Seaton TB, Rowe E, Jelinek CA, Raskin P, Lebovitz HE, Weinstein SP, Sibutramine/Diabetes Clinical Study Group.
    Diabetes Obes Metab; 2000 Jun; 2(3):175-87. PubMed ID: 11220553
    [Abstract] [Full Text] [Related]

  • 45. [Sustained weight reduction after cessation of obesity treatment with Sibutramine].
    Wirth A.
    Dtsch Med Wochenschr; 2004 Apr 30; 129(18):1002-5. PubMed ID: 15131746
    [Abstract] [Full Text] [Related]

  • 46. Cardiovascular effects of sibutramine in the treatment of obese adolescents: results of a randomized, double-blind, placebo-controlled study.
    Daniels SR, Long B, Crow S, Styne D, Sothern M, Vargas-Rodriguez I, Harris L, Walch J, Jasinsky O, Cwik K, Hewkin A, Blakesley V, Sibutramine Adolescent Study Group.
    Pediatrics; 2007 Jul 30; 120(1):e147-57. PubMed ID: 17576783
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Comparison of the effects of sibutramine and orlistat on obese, poorly-controlled type 2 diabetic patients.
    Chou KM, Huang BY, Fanchiang JK, Chen CH.
    Chang Gung Med J; 2007 Jul 30; 30(6):538-46. PubMed ID: 18350737
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Effect of sibutramine on weight reduction in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Lindholm Å, Bixo M, Björn I, Wölner-Hanssen P, Eliasson M, Larsson A, Johnson O, Poromaa IS.
    Fertil Steril; 2008 May 30; 89(5):1221-1228. PubMed ID: 17603048
    [Abstract] [Full Text] [Related]

  • 54. Combined diet and exercise intervention reverses the metabolic syndrome in middle-aged males: results from the Oslo Diet and Exercise Study.
    Anderssen SA, Carroll S, Urdal P, Holme I.
    Scand J Med Sci Sports; 2007 Dec 30; 17(6):687-95. PubMed ID: 17331082
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Does prior authorization of sibutramine improve medication compliance or weight loss?
    Risser JA, Vash PD, Nieto L.
    Obes Res; 2005 Jan 30; 13(1):86-92. PubMed ID: 15761166
    [Abstract] [Full Text] [Related]

  • 60. Medical strategies for weight loss in the overweight and obese patient.
    Di Caro S, Hamad GG, Fernstrom MH, Schauer PR, Bonanomi G.
    Minerva Gastroenterol Dietol; 2006 Dec 30; 52(4):415-30. PubMed ID: 17108871
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.